The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II MMRC trial of extended treatment with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) plus autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM).
 
Todd M. Zimmerman
Honoraria - Celgene; Onyx
Consulting or Advisory Role - Celgene; Onyx
Speakers' Bureau - Celgene; Onyx
 
Kent A. Griffith
No Relationships to Disclose
 
Jagoda Jasielec
No Relationships to Disclose
 
Cara Ann Rosenbaum
Consulting or Advisory Role - Millennium
Speakers' Bureau - Celgene
 
Kathryn McDonnell
No Relationships to Disclose
 
Jessica Waite-Marin
No Relationships to Disclose
 
Jesus G. Berdeja
Research Funding - Bristol-Myers Squibb; Celgene; MEI Pharma; Onyx; Takeda
 
Noopur S. Raje
Honoraria - Amgen; Celgene; Millennium; Onyx
Consulting or Advisory Role - Amgen; Celgene; Millennium; Onyx
Research Funding - Ceylon; Lilly
 
Donna Ellen Reece
Honoraria - Amgen; Celgene; Janssen; Lundbeck; Novartis
Consulting or Advisory Role - Celgene; Janssen; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Millennium; Novartis; Novartis; Otsuka
 
Ravi Vij
Honoraria - Celgene; Onyx
Consulting or Advisory Role - Celgene; Onyx
Speakers' Bureau - Celgene; Onyx
Research Funding - Onyx
 
Mattina Alonge
No Relationships to Disclose
 
Shaun Rosebeck
No Relationships to Disclose
 
Sandeep Gurbuxani
No Relationships to Disclose
 
Malek Faham
Employment - Sequenta
Stock and Other Ownership Interests - Sequenta
 
Katherine A Kong
Employment - Sequenta
Stock and Other Ownership Interests - Sequenta
 
Joan Levy
No Relationships to Disclose
 
Andrzej J. Jakubowiak
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Karyopharm Therapeutics; Millennium; Onyx; Sanofi; Skyline Diagnostics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen-Cilag; Karyopharm Therapeutics; Onyx; Sanofi; Skyline Diagnostics; Takeda
Speakers' Bureau - Celgene; Onyx